ASH 2016 - Chronic Lymphocytic Leukemia

Conference Correspondent, ASH 2016 - Chronic Lymphocytic Leukemia

Salvage Use of Ibrutinib After allo-HSCT for B-Cell Malignancies: A Study of the French Cooperative Group for CLL, the French Society for Blood and Marrow Transplantation (SFGM-TC), and the EBMT Chronic Malignancy and Lymphoma Working Parties

Conference Correspondent, ASH 2016 - Chronic Lymphocytic Leukemia

CLL2-BIG – A Novel Treatment Regimen of Bendamustine Followed by GA101 and Ibrutinib Followed by Ibrutinib and GA101 Maintenance in Patients with Chronic Lymphocytic Leukemia (CLL): Results of a Phase 2 Trial

Conference Correspondent, ASH 2016 - Chronic Lymphocytic Leukemia

Optimal Sequencing of Ibrutinib, Idelalisib, and Venetoclax in CLL: Results from a Large Multicenter Study of 683 US Patients

Conference Correspondent, ASH 2016 - Chronic Lymphocytic Leukemia

Comparing Healthcare Utilization of 2 Drug Regimens in Patients with CLL

Conference Correspondent, ASH 2016 - Chronic Lymphocytic Leukemia

Multicenter Open-Label Phase 2 Study of Ibrutinib in Chronic Graft-versus-Host Disease (cGVHD) After Failure of Corticosteroids

Conference Correspondent, ASH 2016 - Chronic Lymphocytic Leukemia

Reviewing the Demographics and First-Line Treatment Patterns in Patients with CLL

Conference Correspondent, ASH 2016 - Chronic Lymphocytic Leukemia

Phase 1b Results of a Phase 1b/2 Study of Obinutuzumab, Ibrutinib, and Venetoclax in Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)

Conference Correspondent, ASH 2016 - Chronic Lymphocytic Leukemia

Changes in Clinical Stage Identify Different Response Categories Among Patients in iwCLL PR: Analysis of CLL Patients on the RESONATE Study

Conference Correspondent, ASH 2016 - Chronic Lymphocytic Leukemia

PD-1 Blockade with Pembrolizumab in Relapsed CLL Including Richter’s Transformation: An Updated Report from a Phase 2 Trial (MC1485)

Conference Correspondent, ASH 2016 - Chronic Lymphocytic Leukemia

Integrated and Long-Term Safety Analysis of Ibrutinib in Patients with Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

1
2

Page 1 of 2
Results 1 - 10 of 20

SUBSCRIBE

© Amplity Health. All rights reserved.

Subscribe Today!

To sign up for our newsletter or print publications, please enter your contact information below.

I'd like to receive:

AHDB Print Edition

AHDB Weekly e‑Newsletter

I have reviewed and consent to the terms of AHDB's Privacy Policy, and AHDB has my permission to retain my information in its database, and to forward pertinent communications to me.